NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Collection of the Thrombo-VaxCov Cohort

WithdrawnN/A

Sponsor: University Hospital, Lille

Conditions: Covid19, SARS-CoV Infection, Venous Thrombosis, Thrombocytopenia, Vaccination; Complications

Interventions: Retrospective data and biological samples

Countries: France

In the context of anti-Covid19 vaccination, atypical thrombosis have occured and potential link with vaccination is under investigation. This study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after antiCovid vaccination.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

atypical thrombosis symptoms onset within 4 weeks of vaccination

Exclusion Criteria:

children

Locations (1)

Lille, France